This report aims to provide a comprehensive presentation of the global market for Breast Cancer Predictive Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Predictive Genetic Testing. This report contains market size and forecasts of Breast Cancer Predictive Genetic Testing in global, including the following market information:
Global Breast Cancer Predictive Genetic Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Breast Cancer Predictive Genetic Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
High Penetrant Genes Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Breast Cancer Predictive Genetic Testing include Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation and NeoGenomics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Breast Cancer Predictive Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Predictive Genetic Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Breast Cancer Predictive Genetic Testing Market Segment Percentages, by Type, 2022 (%)
High Penetrant Genes
Intermediate Penetrant Genes
Low Penetrant Genes
Global Breast Cancer Predictive Genetic Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Breast Cancer Predictive Genetic Testing Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Breast Cancer Predictive Genetic Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Breast Cancer Predictive Genetic Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Breast Cancer Predictive Genetic Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Breast Cancer Predictive Genetic Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Thermo Fisher Scientific
PerkinElmer
Quest Diagnostics
Myriad Genetics
Iverson Genetics
Cancer Genetics
OncoCyte Corporation
NeoGenomics
Invitae
Outline of Major Chapters:
Chapter 1: Introduces the definition of Breast Cancer Predictive Genetic Testing, market overview.
Chapter 2: Global Breast Cancer Predictive Genetic Testing market size in revenue.
Chapter 3: Detailed analysis of Breast Cancer Predictive Genetic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Breast Cancer Predictive Genetic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Breast Cancer Predictive Genetic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Breast Cancer Predictive Genetic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Breast Cancer Predictive Genetic Testing Overall Market Size
2.1 Global Breast Cancer Predictive Genetic Testing Market Size: 2022 VS 2029
2.2 Global Breast Cancer Predictive Genetic Testing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Breast Cancer Predictive Genetic Testing Players in Global Market
3.2 Top Global Breast Cancer Predictive Genetic Testing Companies Ranked by Revenue
3.3 Global Breast Cancer Predictive Genetic Testing Revenue by Companies
3.4 Top 3 and Top 5 Breast Cancer Predictive Genetic Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Breast Cancer Predictive Genetic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Predictive Genetic Testing Players in Global Market
3.6.1 List of Global Tier 1 Breast Cancer Predictive Genetic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Predictive Genetic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Breast Cancer Predictive Genetic Testing Market Size Markets, 2022 & 2029
4.1.2 High Penetrant Genes
4.1.3 Intermediate Penetrant Genes
4.1.4 Low Penetrant Genes
4.2 By Type - Global Breast Cancer Predictive Genetic Testing Revenue & Forecasts
4.2.1 By Type - Global Breast Cancer Predictive Genetic Testing Revenue, 2018-2023
4.2.2 By Type - Global Breast Cancer Predictive Genetic Testing Revenue, 2024-2029
4.2.3 By Type - Global Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Breast Cancer Predictive Genetic Testing Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Breast Cancer Predictive Genetic Testing Revenue & Forecasts
5.2.1 By Application - Global Breast Cancer Predictive Genetic Testing Revenue, 2018-2023
5.2.2 By Application - Global Breast Cancer Predictive Genetic Testing Revenue, 2024-2029
5.2.3 By Application - Global Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Breast Cancer Predictive Genetic Testing Market Size, 2022 & 2029
6.2 By Region - Global Breast Cancer Predictive Genetic Testing Revenue & Forecasts
6.2.1 By Region - Global Breast Cancer Predictive Genetic Testing Revenue, 2018-2023
6.2.2 By Region - Global Breast Cancer Predictive Genetic Testing Revenue, 2024-2029
6.2.3 By Region - Global Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Breast Cancer Predictive Genetic Testing Revenue, 2018-2029
6.3.2 US Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.3.3 Canada Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.3.4 Mexico Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Breast Cancer Predictive Genetic Testing Revenue, 2018-2029
6.4.2 Germany Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.4.3 France Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.4.4 U.K. Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.4.5 Italy Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.4.6 Russia Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.4.7 Nordic Countries Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.4.8 Benelux Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Breast Cancer Predictive Genetic Testing Revenue, 2018-2029
6.5.2 China Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.5.3 Japan Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.5.4 South Korea Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.5.5 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.5.6 India Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Breast Cancer Predictive Genetic Testing Revenue, 2018-2029
6.6.2 Brazil Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.6.3 Argentina Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Breast Cancer Predictive Genetic Testing Revenue, 2018-2029
6.7.2 Turkey Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.7.3 Israel Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.7.4 Saudi Arabia Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
6.7.5 UAE Breast Cancer Predictive Genetic Testing Market Size, 2018-2029
7 Breast Cancer Predictive Genetic Testing Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Breast Cancer Predictive Genetic Testing Major Product Offerings
7.1.4 Roche Breast Cancer Predictive Genetic Testing Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Major Product Offerings
7.2.4 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 PerkinElmer
7.3.1 PerkinElmer Company Summary
7.3.2 PerkinElmer Business Overview
7.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Major Product Offerings
7.3.4 PerkinElmer Breast Cancer Predictive Genetic Testing Revenue in Global Market (2018-2023)
7.3.5 PerkinElmer Key News & Latest Developments
7.4 Quest Diagnostics
7.4.1 Quest Diagnostics Company Summary
7.4.2 Quest Diagnostics Business Overview
7.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Major Product Offerings
7.4.4 Quest Diagnostics Breast Cancer Predictive Genetic Testing Revenue in Global Market (2018-2023)
7.4.5 Quest Diagnostics Key News & Latest Developments
7.5 Myriad Genetics
7.5.1 Myriad Genetics Company Summary
7.5.2 Myriad Genetics Business Overview
7.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Major Product Offerings
7.5.4 Myriad Genetics Breast Cancer Predictive Genetic Testing Revenue in Global Market (2018-2023)
7.5.5 Myriad Genetics Key News & Latest Developments
7.6 Iverson Genetics
7.6.1 Iverson Genetics Company Summary
7.6.2 Iverson Genetics Business Overview
7.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Major Product Offerings
7.6.4 Iverson Genetics Breast Cancer Predictive Genetic Testing Revenue in Global Market (2018-2023)
7.6.5 Iverson Genetics Key News & Latest Developments
7.7 Cancer Genetics
7.7.1 Cancer Genetics Company Summary
7.7.2 Cancer Genetics Business Overview
7.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Major Product Offerings
7.7.4 Cancer Genetics Breast Cancer Predictive Genetic Testing Revenue in Global Market (2018-2023)
7.7.5 Cancer Genetics Key News & Latest Developments
7.8 OncoCyte Corporation
7.8.1 OncoCyte Corporation Company Summary
7.8.2 OncoCyte Corporation Business Overview
7.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Major Product Offerings
7.8.4 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Revenue in Global Market (2018-2023)
7.8.5 OncoCyte Corporation Key News & Latest Developments
7.9 NeoGenomics
7.9.1 NeoGenomics Company Summary
7.9.2 NeoGenomics Business Overview
7.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Major Product Offerings
7.9.4 NeoGenomics Breast Cancer Predictive Genetic Testing Revenue in Global Market (2018-2023)
7.9.5 NeoGenomics Key News & Latest Developments
7.10 Invitae
7.10.1 Invitae Company Summary
7.10.2 Invitae Business Overview
7.10.3 Invitae Breast Cancer Predictive Genetic Testing Major Product Offerings
7.10.4 Invitae Breast Cancer Predictive Genetic Testing Revenue in Global Market (2018-2023)
7.10.5 Invitae Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Breast Cancer Predictive Genetic Testing Market Opportunities & Trends in Global Market
Table 2. Breast Cancer Predictive Genetic Testing Market Drivers in Global Market
Table 3. Breast Cancer Predictive Genetic Testing Market Restraints in Global Market
Table 4. Key Players of Breast Cancer Predictive Genetic Testing in Global Market
Table 5. Top Breast Cancer Predictive Genetic Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Breast Cancer Predictive Genetic Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Breast Cancer Predictive Genetic Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Breast Cancer Predictive Genetic Testing Product Type
Table 9. List of Global Tier 1 Breast Cancer Predictive Genetic Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Breast Cancer Predictive Genetic Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Breast Cancer Predictive Genetic Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Breast Cancer Predictive Genetic Testing Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Breast Cancer Predictive Genetic Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Breast Cancer Predictive Genetic Testing Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Breast Cancer Predictive Genetic Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Breast Cancer Predictive Genetic Testing Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Breast Cancer Predictive Genetic Testing Product Offerings
Table 32. Roche Breast Cancer Predictive Genetic Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Thermo Fisher Scientific Company Summary
Table 35. Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Product Offerings
Table 36. Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Thermo Fisher Scientific Key News & Latest Developments
Table 38. PerkinElmer Company Summary
Table 39. PerkinElmer Breast Cancer Predictive Genetic Testing Product Offerings
Table 40. PerkinElmer Breast Cancer Predictive Genetic Testing Revenue (US$, Mn) & (2018-2023)
Table 41. PerkinElmer Key News & Latest Developments
Table 42. Quest Diagnostics Company Summary
Table 43. Quest Diagnostics Breast Cancer Predictive Genetic Testing Product Offerings
Table 44. Quest Diagnostics Breast Cancer Predictive Genetic Testing Revenue (US$, Mn) & (2018-2023)
Table 45. Quest Diagnostics Key News & Latest Developments
Table 46. Myriad Genetics Company Summary
Table 47. Myriad Genetics Breast Cancer Predictive Genetic Testing Product Offerings
Table 48. Myriad Genetics Breast Cancer Predictive Genetic Testing Revenue (US$, Mn) & (2018-2023)
Table 49. Myriad Genetics Key News & Latest Developments
Table 50. Iverson Genetics Company Summary
Table 51. Iverson Genetics Breast Cancer Predictive Genetic Testing Product Offerings
Table 52. Iverson Genetics Breast Cancer Predictive Genetic Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Iverson Genetics Key News & Latest Developments
Table 54. Cancer Genetics Company Summary
Table 55. Cancer Genetics Breast Cancer Predictive Genetic Testing Product Offerings
Table 56. Cancer Genetics Breast Cancer Predictive Genetic Testing Revenue (US$, Mn) & (2018-2023)
Table 57. Cancer Genetics Key News & Latest Developments
Table 58. OncoCyte Corporation Company Summary
Table 59. OncoCyte Corporation Breast Cancer Predictive Genetic Testing Product Offerings
Table 60. OncoCyte Corporation Breast Cancer Predictive Genetic Testing Revenue (US$, Mn) & (2018-2023)
Table 61. OncoCyte Corporation Key News & Latest Developments
Table 62. NeoGenomics Company Summary
Table 63. NeoGenomics Breast Cancer Predictive Genetic Testing Product Offerings
Table 64. NeoGenomics Breast Cancer Predictive Genetic Testing Revenue (US$, Mn) & (2018-2023)
Table 65. NeoGenomics Key News & Latest Developments
Table 66. Invitae Company Summary
Table 67. Invitae Breast Cancer Predictive Genetic Testing Product Offerings
Table 68. Invitae Breast Cancer Predictive Genetic Testing Revenue (US$, Mn) & (2018-2023)
Table 69. Invitae Key News & Latest Developments
List of Figures
Figure 1. Breast Cancer Predictive Genetic Testing Segment by Type in 2022
Figure 2. Breast Cancer Predictive Genetic Testing Segment by Application in 2022
Figure 3. Global Breast Cancer Predictive Genetic Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Breast Cancer Predictive Genetic Testing Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Breast Cancer Predictive Genetic Testing Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Breast Cancer Predictive Genetic Testing Revenue in 2022
Figure 8. By Type - Global Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
Figure 9. By Application - Global Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
Figure 10. By Type - Global Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
Figure 12. By Application - Global Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
Figure 14. By Region - Global Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
Figure 15. By Country - North America Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
Figure 16. US Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
Figure 20. Germany Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 21. France Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
Figure 28. China Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 32. India Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
Figure 34. Brazil Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Breast Cancer Predictive Genetic Testing Revenue Market Share, 2018-2029
Figure 37. Turkey Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Breast Cancer Predictive Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Breast Cancer Predictive Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. PerkinElmer Breast Cancer Predictive Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Quest Diagnostics Breast Cancer Predictive Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Myriad Genetics Breast Cancer Predictive Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Iverson Genetics Breast Cancer Predictive Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cancer Genetics Breast Cancer Predictive Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. OncoCyte Corporation Breast Cancer Predictive Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. NeoGenomics Breast Cancer Predictive Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Invitae Breast Cancer Predictive Genetic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
